BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6485485)

  • 21. [Recent acquisitions in the study of Wilson's disease].
    Sternlieb I
    Rev Med Chir Mal Foie; 1965 Sep; 40(4):199-204. PubMed ID: 5851771
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnosis of symptomatic forms of wilson's disease (author's transl)].
    Marecek Z; Heyrovský A; Jindrová M; Dvorák J
    Cas Lek Cesk; 1976 Apr; 115(13):397-400. PubMed ID: 1260817
    [No Abstract]   [Full Text] [Related]  

  • 23. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH; GITLIN D
    Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898
    [No Abstract]   [Full Text] [Related]  

  • 24. Persistent transaminasemia and fatty liver. Their use in the diagnosis of presymptomatic Wilson's disease.
    Stillman AE; Rohr LR
    Am J Dis Child; 1982 Mar; 136(3):242-4. PubMed ID: 7064950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
    CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM
    Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058
    [No Abstract]   [Full Text] [Related]  

  • 26. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of the protective effects on the erythrocytes of ceruloplasmin from the blood of healthy donors and patients with hepatocerebral dystrophy].
    Saenko EL; Skorobagat'ko OV; Iaropolov AI
    Biull Eksp Biol Med; 1990 Oct; 110(10):368-70. PubMed ID: 2279084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serologic and hematologic findings in Wilson's disease].
    Engelmann L; Schneider D; von Baehr R
    Z Gesamte Inn Med; 1973 Jan; 28(1):17-21. PubMed ID: 4694331
    [No Abstract]   [Full Text] [Related]  

  • 29. Never forget aceruloplasminemia in case of highly suggestive Wilson's disease score.
    Kerkhof M; Honkoop P
    Hepatology; 2014 Apr; 59(4):1645-7. PubMed ID: 24002824
    [No Abstract]   [Full Text] [Related]  

  • 30. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular forms of ceruloplasmin in hepatolenticular degeneration and their interaction with human erythrocyte ceruloplasmin receptor.
    Puchkova LV; Verbina IA; Denezhkina VV; Vakharlovskii VG; Voitsekhovskii BL; Gaitskhoki VS; Neifakh SA
    Biomed Sci; 1990; 1(5):460-6. PubMed ID: 1966785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some aspects of the relation of ceruloplasmin to Wilson's disease.
    SCHEINBERG IH; HARRIS RS; MORELL AG; DUBIN D
    Neurology; 1958 Apr; 8(Suppl 1):44-51. PubMed ID: 13541603
    [No Abstract]   [Full Text] [Related]  

  • 33. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sherlock Holmes' magnifying glass to identify Wilson's disease?
    Delpre G; Niv Y
    Am J Gastroenterol; 1998 Dec; 93(12):2635-6. PubMed ID: 9860458
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of immunologic and enzymatic methods for ceruloplasmin quantitation in Wilson's disease.
    Rosenberg EB; Strickland GT; Feng YS; Blackwell RQ
    Taiwan Yi Xue Hui Za Zhi; 1971 Jan; 70(1):49-53. PubMed ID: 4996661
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations on ceruloplasmin in Wilson's disease.
    SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of apo- and holo-forms of ceruloplasmin in patients with Wilson's disease using native polyacrylamide gel electrophoresis.
    Hirano K; Ogihara T; Ogihara H; Hiroi M; Hasegawa M; Tamai H
    Clin Biochem; 2005 Jan; 38(1):9-12. PubMed ID: 15607310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapid screening test for deficiency of plasma ceruloplasmin and its value in the diagnosis of Wilson's disease.
    AISEN P; SCHORR JB; MORELL AG; GOLD RZ; SCHEINBERG IH
    Am J Med; 1960 Apr; 28():550-4. PubMed ID: 13792199
    [No Abstract]   [Full Text] [Related]  

  • 39. Liver transplantation for Wilson's disease.
    Sevmis S; Karakayali H; Aliosmanoglu I; Yilmaz U; Ozcay F; Torgay A; Arslan G; Haberal M
    Transplant Proc; 2008; 40(1):228-30. PubMed ID: 18261593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.